▶ 調査レポート

獣医疼痛管理の世界市場2020-2025

• 英文タイトル:Veterinary Pain Management Market - Growth, Trends, and Forecast (2020 - 2025)

Mordor Intelligenceが調査・発行した産業分析レポートです。獣医疼痛管理の世界市場2020-2025 / Veterinary Pain Management Market - Growth, Trends, and Forecast (2020 - 2025) / D0MOR-NV209資料のイメージです。• レポートコード:D0MOR-NV209
• 出版社/出版日:Mordor Intelligence / 2020年8月
• レポート形態:英文、PDF、126ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥629,000 (USD4,250)▷ お問い合わせ
  Team User¥703,000 (USD4,750)▷ お問い合わせ
  Corporate License¥888,000 (USD6,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、獣医疼痛管理の世界市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品別(薬物、デバイス)分析、用途別(変形性関節症・関節痛、術後痛み、癌、その他)分析、動物別(コンパニオン、家畜)分析、エンドユーザー別(病院・クリニック、小売店・その他)分析、地域別分析、競争状況、市場機会・将来動向などを整理しました。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・市場動向
・獣医疼痛管理の世界市場規模:製品別(薬物、デバイス)
・獣医疼痛管理の世界市場規模:用途別(変形性関節症・関節痛、術後痛み、癌、その他)
・獣医疼痛管理の世界市場規模:動物別(コンパニオン、家畜)
・獣医疼痛管理の世界市場規模:エンドユーザー別(病院・クリニック、小売店・その他)
・獣医疼痛管理の世界市場規模:地域別
・競争状況
・市場機会・将来動向

Veterinary Pain Management market, being a competitive one, is expected to observe growth owing to the high prevalence of inflammatory and painful diseases in the animal population. According to a report published in Nature, in April 2018, the annual period prevalence of osteoarthritis diagnosis in dogs under primary veterinary care in the United Kingdom was estimated to be 2.5%. Similarly, according to the Animal Cancer Foundation, 65 million dogs and 32 million cats in the United States were diagnosed with cancer during the year 2017. Moreover, approximately 6 million new cancer diagnoses are made in pets, each year.

Additionally, as per the results of the 2017-2018 APPA (American Pet Products Association) National Pet Owners Survey, 10% of dogs and 8% each of cats and birds have undergone surgical procedures, for some reason or the other. This indicate that there is a high prevalence of the diseases associated with pain in animals which is a fuelling factor for the market studied.

In addition to the aforementioned factors, the rise in need for easily accessible and affordable treatment procedures and an increase in awareness about animal health and welfare are also expected to propel the growth of the veterinary pain management market.

[Key Market Trends]
Laser Therapy is Expected to Witness a Healthy Growth Over the Forecasted Period
The therapeutic laser treatment of osteoarthritis (OA) in dogs and cats is currently the most common laser therapy. The laser intensity in OA is most appropriate as 8-10 J/cm2. Tendonitis may also be benefitted from laser therapy, due to the inflammation associated with the disease.

Generally, the price of therapeutic laser equipment can range from around USD 30 to around USD 10,000, based upon the size of it, the facilities it provides, and the technologies it uses. There are some laser devices that can be used both for surgical and therapeutic purposes, by controlling the level of emission. These devices can have higher prices, even up to USD 40,000. Some of the laser therapy brands that are in the market for veterinary pain management include B-Cure Laser, TENDLITE, Lumasoothe, iReliev, Keebomed, MLS Laser Therapy (ASAveterinary), among others. The end-users primarily include pet owners, veterinary clinics, and hospitals. Owing to the aforementioned factors, the segment is expected to witness considerable growth over the forecast period.

[India to Witness Rapid Growth in Asia-Pacific Region]
The large livestock population in India is a major factor contributing to the market growth. According to the National Dairy Development Board, India, the total livestock population in India, as recorded in 2019, is around 536 million.

Animal husbandry has observed a significant increase over the years, in India. The factors behind the growth of the animal health market are the adoption of innovative technologies that are used to prevent and cure various diseases associated with farm and companion animals. Animal health companies now deal with therapeutics, preventive measures, and productivity enhancement.

Over the past few years, many global animal health companies, such as Ceva and Sanofi, have entered the animal health market in India, owing to large growth opportunities in the country. For example, India has approximately 120 million dairy cows, and hence, is the largest milk producer in the world, having a production capacity almost equivalent to that of the entire European Union. In addition, India is also the fifth-largest producer of chicken meat and a major exporter of beef. Therefore, owing to the rising significance of this country in the international market, it is expected to witness rapid growth.

[Competitive Landscape]
Veterinary healthcare has rapidly evolved over the last few years, where technology concerning biotech, genomics, artificial intelligence, cloud computing, and big data has grown massively, bringing competition among large animal health companies and collaborations with technologically advanced start-ups. Also, the industry observed significant mergers and acquisitions in recent years, such as between Boehringer Ingelheim Animal Health and Merial. Thus, the veterinary healthcare market has become a very competitive industry and this factor is beneficial for the market studied as companies are obtaining opportunities to establish their presence.

[Reasons to Purchase this report]
• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

レポート目次

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growth in Prevalence of Painful and Inflammatory Diseases in Animals
4.2.2 Rise in Need for Easily Accessible and Affordable Treatment Procedures
4.2.3 Increase in Awareness about Animal Health and Welfare
4.3 Market Restraints
4.3.1 Side Effects Associated with Treatment
4.3.2 High Cost of Certain Products
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Drugs
5.1.1.1 NSAIDs
5.1.1.2 Anesthetics
5.1.1.3 Opioids
5.1.1.4 Others
5.1.2 Devices
5.1.2.1 Laser Therapy
5.1.2.2 Electromagnetic Therapy
5.2 By Application
5.2.1 Osteoarthritis and Joint Pain
5.2.2 Postoperative Pain
5.2.3 Cancer
5.2.4 Others
5.3 By Animal Type
5.3.1 Companion
5.3.2 Livestock
5.4 By End User
5.4.1 Hospitals and Clinics
5.4.2 Retail Outlets and Others
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle-East and Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle-East and Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 COMPANY PROFILES
6.1.1 Assisi Animal Health
6.1.2 Boehringer Ingelheim
6.1.3 Ceva Sante Animale
6.1.4 Chanelle Veterinary Limited
6.1.5 Dechra Pharmaceuticals PLC
6.1.6 Elanco
6.1.7 Norbrook
6.1.8 Vetoquinol SA
6.1.9 Zoetis Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS